The respiratory system in connective tissue disorders

被引:77
作者
Crestani, B [1 ]
机构
[1] Hop Bichat Claude Bernard, Serv Pneumol, F-75877 Paris, France
关键词
erythematosus; inflammatory myopathies; rheumatoid arthritis; scleroderma; Sjogren's syndrome; systemic lupus;
D O I
10.1111/j.1398-9995.2005.00761.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
The connective tissue disorders (also called collagen vascular diseases) represent an heterogeneous group of immunologically mediated inflammatory disorders with a large variety of affected organs besides the lungs. The respiratory system may be involved in all its components: airways, vessels, parenchyma, pleura, respiratory muscles, etc. The frequency, clinical presentation, prognosis and response to therapy vary, depending on the pattern of involvement as well as on the underlying connective tissue disorders. The subject of this review is to describe the most frequent type of lung disorders observed in patients with connective tissue disease (CTD). We will focus on the most frequent CTD: systemic lupus erythematosus, rheumatoid arthritis, scleroderma, Sjogren's syndrome, dermatopolymyositis and mixed CTD.
引用
收藏
页码:715 / 734
页数:20
相关论文
共 187 条
  • [1] ACUTE REVERSIBLE HYPOXEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    ABRAMSON, SB
    DOBRO, J
    EBERLE, MA
    BENTON, M
    REIBMAN, J
    EPSTEIN, H
    RAPOPORT, DM
    BELMONT, HM
    GOLDRING, RM
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 114 (11) : 941 - 947
  • [2] CANCER IN SYSTEMIC-SCLEROSIS
    ABUSHAKRA, M
    GUILLEMIN, F
    LEE, P
    [J]. ARTHRITIS AND RHEUMATISM, 1993, 36 (04): : 460 - 464
  • [3] ABUSHAKRA M, 1995, J RHEUMATOL, V22, P1265
  • [4] ACUTE AND LONG-TERM EFFECTS OF NIFEDIPINE ON PULMONARY AND SYSTEMIC HEMODYNAMICS IN PATIENTS WITH PULMONARY-HYPERTENSION ASSOCIATED WITH DIFFUSE SYSTEMIC-SCLEROSIS, THE CREST SYNDROME AND MIXED CONNECTIVE-TISSUE DISEASE
    ALPERT, MA
    PRESSLY, TA
    MUKERJI, V
    LAMBERT, CR
    MUKERJI, B
    PANAYIOTOU, H
    SHARP, GC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (17) : 1687 - 1691
  • [5] PREDICTORS OF SURVIVAL IN SYSTEMIC-SCLEROSIS (SCLERODERMA)
    ALTMAN, RD
    MEDSGER, TA
    BLOCH, DA
    MICHEL, BA
    [J]. ARTHRITIS AND RHEUMATISM, 1991, 34 (04): : 403 - 413
  • [6] PULMONARY-FUNCTION OF NONSMOKING PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
    ANDONOPOULOS, AP
    CONSTANTOPOULOS, SH
    GALANOPOULOU, V
    DROSOS, AA
    ACRITIDIS, NC
    MOUTSOPOULOS, HM
    [J]. CHEST, 1988, 94 (02) : 312 - 315
  • [7] [Anonymous], 2000, AM J RESP CRIT CARE, V161, P646, DOI DOI 10.1164/AJRCCM.161.2.ATS3-00
  • [8] Nonspecific interstitial pneumonia associated with polymyositis and dermatomyositis - Serial high-resolution CT findings and functional correlation
    Arakawa, H
    Yamada, H
    Kurihara, Y
    Nakajima, Y
    Takeda, A
    Fukushima, Y
    Fujioka, M
    [J]. CHEST, 2003, 123 (04) : 1096 - 1103
  • [9] Tumour necrosis factor and other proinflammatory cytokines in systemic lupus erythematosus: a rationale for therapeutic intervention
    Aringer, M
    Smolen, J
    [J]. LUPUS, 2004, 13 (05) : 344 - 347
  • [10] Catastrophic antiphospholipid syndrome -: Clinical and laboratory features of 50 patients
    Asherson, RA
    Cervera, R
    Piette, JC
    Font, J
    Lie, JT
    Burcoglu, A
    Lim, K
    Muñoz-Rodríguez, FJ
    Levy, RA
    Boué, F
    Rossert, J
    Ingelmo, M
    [J]. MEDICINE, 1998, 77 (03) : 195 - 207